AI
VERA icon

Alphabet Inc’s Vera Therapeutics VERA Stock Holding History

Alphabet Inc’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Hold
241,264
– – 0.01% 21
2026
Q1 		$9.71M Hold
241,264
– – 0.24% 17
2025
Q4 		$12.2M Hold
241,264
– – 0.47% 14
2025
Q3 		$7.01M Hold
241,264
– – 0.29% 21
2025
Q2 		$5.68M Hold
241,264
– – 0.27% 17
2025
Q1 		$5.8M Hold
241,264
– – 0.37% 18
2024
Q4 		$10.2M Hold
241,264
– – 0.59% 12
2024
Q3 		$10.7M Hold
241,264
– – 0.58% 15
2024
Q2 		$8.73M Hold
241,264
– – 0.44% 15
2024
Q1 		$10.4M Sell
241,264
-60,316
-20% -$2.15M 0.41% 17
2023
Q4 		$4.64M Hold
301,580
– – 0.22% 25
2023
Q3 		$4.13M Hold
301,580
– – 0.27% 24
2023
Q2 		$4.84M Hold
301,580
– – 0.26% 26
2023
Q1 		$2.34M Hold
301,580
– – 0.13% 31
2022
Q4 		$5.84M Hold
301,580
– – 0.34% 26
2022
Q3 		$6.43M Hold
301,580
– – 0.33% 26
2022
Q2 		$4.11M Hold
301,580
– – 0.22% 35
2022
Q1 		$7.08M Sell
301,580
-412,078
-58% -$8.87M 0.23% 36
2021
Q4 		$19.1M Sell
713,658
-231,133
-24% -$5.11M 0.46% 27
2021
Q3 		$16.4M Hold
944,791
– – 0.39% 25
2021
Q2 		$12.5M Buy
+944,791
New +$14.7M 0.26% 25

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Alphabet Inc's VERA Position: Q2 2026 in Review

Alphabet Inc held its Vera Therapeutics (VERA) position steady in Q2 2026 at 241,264 shares worth $10.4M. The position accounts for 0.01% of the portfolio, ranked #21.

Alphabet Inc first reported a position in VERA in Q2 2021 and has held it in 21 quarters since. The position peaked at $19.1M in Q4 2021. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Alphabet Inc held 241,264 shares of Vera Therapeutics worth $10.4M as of Q2 2026.
  • Alphabet Inc left its Vera Therapeutics share count unchanged in Q2 2026.
  • Vera Therapeutics made up 0.01% of Alphabet Inc's portfolio in Q2 2026, its #21 holding.
  • Alphabet Inc first reported a position in Vera Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • Alphabet Inc's Vera Therapeutics position peaked at $19.1M in Q4 2021.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Alphabet Inc's 13F filing for Q2 2026, filed 7 Aug 2026.